ADVFN US – Market Content Editor
-
Meta introduces prescription-ready AI glasses starting at $499
Meta (NASDAQ:META) on Tuesday unveiled two new AI-powered smart glasses designed for users who require prescription lenses: the Ray-Ban Meta Blayzer Optics (Gen 2) and the Ray-Ban Meta Scriber Optics (Gen 2). The new models include features such as overextension hinges, interchangeable nose pads, and adjustable temple tips to improve comfort and fit for prescription…
-
Amazon unveils new business credit cards in partnership with U.S. Bank
Amazon (NASDAQ:AMZN) said it will roll out new Prime Business and Amazon Business credit cards this spring, shifting its partnership from American Express to U.S. Bank (USB) and the Mastercard (MA) payment network. Under the new structure, the Prime Business Card will offer 5% cash back on Amazon purchases for Prime members, while the Amazon…
-
CoreWeave shares rise after closing $8.5B financing facility
CoreWeave (NASDAQ:CRWV) shares gained about 6% on Tuesday after the company announced the completion of an $8.5 billion delayed draw term loan facility, alongside broader strength across technology stocks. The financing received investment-grade ratings of A3 from Moody’s and A (low) from DBRS, marking what the company described as the first investment-grade-rated financing tied to…
-
Momentus deploys Vigoride 7 spacecraft carrying 10 payloads on SpaceX mission
Momentus Inc. (NASDAQ:MNTS) announced that its Vigoride 7 Orbital Service Vehicle has been successfully deployed after launching aboard SpaceX’s Transporter-16 mission on March 30. The spacecraft separated from the Falcon 9 rocket at an altitude of roughly 500 kilometers. Following deployment, the vehicle’s 1.6-kilowatt solar arrays successfully unfolded and are now supplying power to the…
-
NVIDIA commits $2 billion investment in Marvell to expand AI infrastructure collaboration
NVIDIA Corporation (NASDAQ:NVDA) announced a $2 billion investment in Marvell Technology Inc. (NASDAQ:MRVL) as part of a strategic partnership aimed at strengthening NVIDIA’s artificial intelligence infrastructure ecosystem through its NVLink Fusion technology. The collaboration will integrate Marvell into NVIDIA’s AI factory and AI-RAN ecosystem using NVLink Fusion, a rack-scale platform designed to help customers build…
-
Opera introduces MCP Connector for Neon browser to enable AI integrations
Opera (NASDAQ:OPRA) has unveiled a new MCP Connector for its Opera Neon browser, allowing external artificial intelligence tools to connect directly to the browser and perform actions within a user’s active browsing session. According to the Norwegian browser developer, the connector allows AI platforms such as Claude, ChatGPT, Lovable, n8n, and OpenClaw to access real-time…
-
Alaska Airlines unveils business class suites for new Europe and Asia routes
Alaska Airlines (NYSE:ALK) has introduced a new International Business Class offering aboard its Boeing 787-9 Dreamliners as the carrier expands service to destinations in Europe and Asia this spring. The upgraded cabin features fully lie-flat suites equipped with privacy doors, direct aisle access, and 18-inch HD entertainment screens. Travelers will also be served multi-course meals…
-
Agios shares jump as FDA discussions advance mitapivat approval pathway
Agios Pharmaceuticals (NASDAQ:AGIO) shares climbed about 12% on Tuesday after the company reported progress toward a potential accelerated U.S. approval for its drug candidate mitapivat in treating sickle cell disease following a pre-supplemental New Drug Application meeting with the U.S. Food and Drug Administration. During the discussions, the FDA advised Agios to submit a proposal…
-
Cintas secures $2 billion revolving credit facility extending to 2031
Cintas Corporation (NASDAQ:CTAS) announced that its wholly owned subsidiary, Cintas Corporation No. 2, entered into a new $2 billion revolving credit facility on March 27, 2026. The agreement includes a letter of credit sub-facility of up to $300 million and a swing line sub-facility of up to $150 million. KeyBank National Association is serving as…
-
Scholar Rock shares jump after FDA resubmission for SMA therapy
Scholar Rock (NASDAQ:SRRK) shares climbed about 12% on Tuesday after the company announced it had resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration for apitegromab, a therapy aimed at treating children and adults with spinal muscular atrophy (SMA). The updated filing includes Catalent Indiana LLC, a facility owned by Novo…